Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

SELL
$98.98 - $115.74 $12,372 - $14,467
-125 Reduced 4.25%
2,815 $325,000
Q2 2023

Aug 14, 2023

SELL
$96.34 - $112.38 $71,580 - $83,498
-743 Reduced 20.17%
2,940 $302,000
Q1 2023

May 11, 2023

SELL
$107.32 - $113.5 $874,228 - $924,571
-8,146 Reduced 68.86%
3,683 $401,000
Q4 2022

Feb 08, 2023

SELL
$62.39 - $113.8 $1.16 Million - $2.12 Million
-18,609 Reduced 61.14%
11,829 $1.35 Million
Q3 2022

Nov 09, 2022

BUY
$58.92 - $84.67 $19,384 - $27,856
329 Added 1.09%
30,438 $1.88 Million
Q2 2022

Aug 10, 2022

SELL
$79.4 - $116.36 $77,335 - $113,334
-974 Reduced 3.13%
30,109 $2.4 Million
Q1 2022

May 12, 2022

SELL
$86.42 - $109.81 $449,902 - $571,670
-5,206 Reduced 14.35%
31,083 $3.27 Million
Q4 2021

Feb 10, 2022

SELL
$98.56 - $119.91 $243,936 - $296,777
-2,475 Reduced 6.38%
36,289 $3.91 Million
Q3 2021

Nov 12, 2021

BUY
$91.91 - $110.37 $260,472 - $312,788
2,834 Added 7.89%
38,764 $4.25 Million
Q2 2021

Aug 06, 2021

BUY
$86.24 - $95.92 $116,337 - $129,396
1,349 Added 3.9%
35,930 $3.37 Million
Q1 2021

May 10, 2021

BUY
$71.83 - $95.48 $65,221 - $86,695
908 Added 2.7%
34,581 $3.19 Million
Q4 2020

Feb 10, 2021

BUY
$67.0 - $84.39 $341,633 - $430,304
5,099 Added 17.84%
33,673 $2.47 Million
Q3 2020

Nov 13, 2020

BUY
$55.23 - $79.93 $1.09 Million - $1.57 Million
19,678 Added 221.2%
28,574 $2.23 Million
Q2 2020

Aug 10, 2020

BUY
$30.2 - $56.98 $268,659 - $506,894
8,896 New
8,896 $494,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.